Mar 12, 2020 4:45pm EDT iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO
Mar 02, 2020 4:30pm EST iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split
Dec 23, 2019 8:30am EST iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing
Dec 16, 2019 4:15pm EST iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming
Dec 10, 2019 4:44pm EST iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production
